Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone

• Published in: Psychoneuroendocrinology 2009-08, Vol.34 (7), p.989-995
• Main Authors: van Bruggen, Marion, van Amelsvoort, Thérèse, Wouters, Luuk, Dingemans, Peter, de Haan, Lieuwe, Linszen, Don
• Format: Article
• Language: English
• Subjects: Adult and adolescent clinical studies; Antipsychotic Agents - adverse effects; Antipsychotic Agents - pharmacology; Behavioral psychophysiology; Benzodiazepines - adverse effects; Benzodiazepines - pharmacology; Biological and medical sciences; Case-Control Studies; Cross-Sectional Studies; Endocrinology & Metabolism; Estradiol; Estradiol - blood; Female; First episode psychosis; Fundamental and applied biological sciences. Psychology; Hormones and behavior; Humans; Male; Medical sciences; Neuropharmacology; Olanzapine; Pharmacology. Drug treatments; Prolactin; Prolactin - blood; Psychiatry; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychology. Psychophysiology; Psychopathology. Psychiatry; Psychopharmacology; Psychoses; Psychotic Disorders - blood; Psychotic Disorders - drug therapy; Psychotic Disorders - psychology; Risperidone; Risperidone - adverse effects; Risperidone - pharmacology; Schizophrenia; Sexual dysfunction; Sexual Dysfunction, Physiological - chemically induced; Sexual Dysfunction, Physiological - metabolism; Young Adult
• ISSN: 0306-4530; 1873-3360
• DOI: 10.1016/j.psyneuen.2009.01.013

Summary Atypical antipsychotics interfere with central and peripheral neurotransmitter systems and with hormonal production. In this study we compared the effect of olanzapine and risperidone on hormonal state and sexual function (by using the Questionnaire for Sexual Dysfunction, QSD) in 40 patients with a first episode psychosis. Results were compared to those of 34 healthy controls. Patients using risperidone had significant higher prolactin levels than patients using olanzapine. Patients using olanzapine had significantly higher 17β-estradiol levels than patients using risperidone. Overall satisfaction with sexuality was less in patients compared to controls, but not different between patients using olanzapine and those using risperidone. Problems with sexual arousal were significantly higher in patients using olanzapine compared to patients using risperidone. A significantly higher frequency of problems with ejaculation and problems with insensibility of genitals were found in patients compared to healthy controls. We found no relation between medication, prolactin and 17β-estradiol levels, frequency of sexual activity, overall satisfaction with sexuality and any of the 18 sexual dysfunctions we investigated. Our results suggests that sexual dysfunction in patients with first episode psychosis might occur despite normal prolactin levels. Also, sexual dysfunction is highly prevalent in healthy controls. Awareness should be raised of potential sexual problems in young adults.